#Chewinggum

Researchers from a major U.S. university have unveiled an antiviral chewing gum designed to help reduce the spread of common viruses, including influenza and herpes simplex. The approach, described in a study published in Molecular Therapy, builds on earlier work showing the gum can lower viral loads in the mouth.

The gum uses ingredients from lablab beans, specifically a protein called FRIL, which can trap and neutralize viruses in the oral cavity. The study’s lead author, a professor from a dental school, says the formulation has the potential to reduce oral viral loads by a substantial margin, echoing prior results against SARS-CoV-2 detected in saliva. This points to a broader use for oral-transmitted viruses.

In an exciting development from the University of Pennsylvania, researchers have introduced an innovative means to combat the spread of common viral infections through the use of antiviral chewing gum. Responding to the global challenge posed by infectious diseases highlighted by the COVID-19 pandemic, researchers have focused on reducing transmission rates of influenza and herpes simplex viruses, which remain prevalent around the world. This approach is highlighted in a study published in Molecular Therapy.